PUBLICATION

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

Authors
Kent, O.A., Chivukula, R.R., Mullendore, M., Wentzel, E.A., Feldmann, G., Lee, K.H., Liu, S., Leach, S.D., Maitra, A., and Mendell, J.T.
ID
ZDB-PUB-101222-35
Date
2010
Source
Genes & Development   24(24): 2754-2759 (Journal)
Registered Authors
Leach, Steven D.
Keywords
Pancreatic cancer, Ras, miR-143/145, microRNA, primary transcript
MeSH Terms
  • Animals
  • Cell Line
  • DNA-Binding Proteins/genetics
  • DNA-Binding Proteins/physiology
  • Down-Regulation/genetics*
  • Humans
  • Mice
  • MicroRNAs/genetics*
  • Pancreatic Neoplasms/etiology*
  • Proto-Oncogene Proteins/genetics
  • Proto-Oncogene Proteins/physiology
  • Proto-Oncogene Proteins p21(ras)/genetics
  • Proto-Oncogene Proteins p21(ras)/physiology
  • Transcription Factors/genetics
  • Transcription Factors/physiology
  • Zebrafish
  • Zebrafish Proteins/genetics
  • ras Proteins/genetics
  • ras Proteins/physiology*
PubMed
21159816 Full text @ Genes & Dev.
Abstract
Although activating mutations in RAS oncogenes are known to result in aberrant signaling through multiple pathways, the role of microRNAs (miRNAs) in the Ras oncogenic program remains poorly characterized. Here we demonstrate that Ras activation leads to repression of the miR-143/145 cluster in cells of human, murine, and zebrafish origin. Loss of miR-143/145 expression is observed frequently in KRAS mutant pancreatic cancers, and restoration of these miRNAs abrogates tumorigenesis. miR-143/145 down-regulation requires the Ras-responsive element-binding protein (RREB1), which represses the miR-143/145 promoter. Additionally, KRAS and RREB1 are targets of miR-143/miR-145, revealing a feed-forward mechanism that potentiates Ras signaling.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping